| ID | 1792 |
|---|
| No | 1792 |
|---|
| Brand Name | LUCISETA |
|---|
| Ingredients | SPARSENTAN 400 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 30'S/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | TO REDUCE PROTEINURIA IN ADULT WITH PRIMARY IMMUNOGLOBULIN A NEPHROPATHY AT RISK OF RAPID DISEASE PROGRESSION, GENERALLY A URINE PROTEIN TO CREATININE RATION >=1.5 G/G |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | WHITE FILM COATED TABLETS, WITH LETTER LUCIUS ON ONE SIDE AND PLAIN ON THE OTHER |
|---|
| Note | |
|---|
| License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 10 L 1036/23 |
|---|
| FDD Registration Date | 30/10/2023 |
|---|
| Expiry Date | 29/10/2026 |
|---|
